The investment will be used to back Bluesight’s acquisition of Medacist, a drug diversion monitoring firm.
The post Thoma Bravo invests in medication intelligence firm Bluesight appeared first on PE Hub.
Powered by WPeMatico
Source: https://www.pehub.com/thoma-bravo-invests-in-medication-intelligence-firm-bluesight/
Comments are closed.